Dow Up 1.31% Nasdaq Up 2.40%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
381.01 Up 14.89(4.07%) 4:00PM EDT
|After Hours : 380.04 Down 0.97 (0.25%) 5:18PM EDT
Prev Close:366.13
Open:370.64
Bid:380.01 x 200
Ask:381.97 x 100
1y Target Est:378.70
Beta:0.85
Next Earnings Date: 4-Nov-14REGN Earnings announcement
Day's Range:366.14 - 381.03
52wk Range:257.69 - 381.03
Volume:1,051,194
Avg Vol (3m):781,257
Market Cap:38.25B
P/E (ttm):108.43
EPS (ttm):3.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNUp 4.07%38.25B
AMGNUp 4.79%109.45B
NVSUp 0.81%214.99B
RHHBYUp 1.51%247.27B

Key Statistics

Forward P/E (1 yr):30.80
P/S (ttm):14.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :10.13
Quarterly EPS Est (Sep-14) :2.57
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.82

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback